AR118247A1 - COMBINATION OF ACTIVE COMPOUNDS - Google Patents

COMBINATION OF ACTIVE COMPOUNDS

Info

Publication number
AR118247A1
AR118247A1 ARP200100595A ARP200100595A AR118247A1 AR 118247 A1 AR118247 A1 AR 118247A1 AR P200100595 A ARP200100595 A AR P200100595A AR P200100595 A ARP200100595 A AR P200100595A AR 118247 A1 AR118247 A1 AR 118247A1
Authority
AR
Argentina
Prior art keywords
alkyl
halogen atoms
different
same
aryl
Prior art date
Application number
ARP200100595A
Other languages
Spanish (es)
Inventor
Ruth Meissner
Sbastien Naud
Andreas Grtz
Jrmy Dufour
Philippe Desbordes
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR118247A1 publication Critical patent/AR118247A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pest Control & Pesticides (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Reivindicación 1: La combinación de compuesto activo, caracterizado por que comprende (A) un compuesto de fórmula [1] en donde A es un anillo heterociclilo bicíclico fusionado, parcialmente saturado o insaturado de 8, 9, 10 u 11 miembros que comprende 1 átomo de nitrógeno y de 0 a 4 más heteroátomos seleccionados independientemente del grupo que consiste en N, O y S; B es un anillo heterociclilo parcialmente saturado o insaturado de 5 miembros que comprende 1, 2, 3 ó 4 heteroátomos seleccionados independientemente del grupo que consiste en N, O y S; Q es C; Z se selecciona del grupo que consiste en átomo de hidrógeno, átomo de halógeno, hidroxilo, alquilo C₁₋₈, alquenilo C₂₋₈, alquinilo C₂₋₈, halógenoalquinilo C₂₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alcoxi C₁₋₈, halógenoalquilo C₁₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, halógenoalquenilo C₂₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, halógenoalcoxi C₁₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, cicloalquilo C₃₋₇, cicloalquenilo C₄₋₇, arilo, heterociclilo, formilo, alquilocarbonilo C₁₋₈, (hidroxiimino)-alquilo C₁₋₈, (alcoxiimino C₁₋₈)-alquilo C₁₋₈, carboxilo, alcoxicarbonilo C₁₋₈, alquilcarbamoílo C₁₋₈, dialquilcarbamoílo C₁₋₈, alquilamino C₁₋₈, dialquilamino C₁₋₈, sulfanilo, alquilsulfanilo C₁₋₈, alquilsulfinilo C₁₋₈, alquilsulfonilo C₁₋₈, trialquilsililo C₁₋₆, ciano y nitro, en donde dicho cicloalquilo C₃₋₇, cicloalquenilo C₄₋₇, arilo y heterociclilo pueden sustituirse con uno o más sustituyentes Zᵃ que pueden ser iguales o diferentes; m es 0, 1, 2, 3 ó 4; n es 0, 1, 2, 3 ó 4; p es 0, 1, 2, 3, 4 ó 5; L es CR¹R² o NR³ en donde R¹ y R² se seleccionan independientemente del grupo que consiste en átomo de hidrógeno, átomo de halógeno, alcoxi C₁₋₈ y alquilo C₁₋₈; R³ se selecciona del grupo que consiste en átomo de hidrógeno, alquilo C₁₋₈, halógenoalquilo C₁₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alquenilo C₂₋₈, halógenoalquenilo C₂₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alquinilo C₃₋₈, halógenoalquinilo C₃₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, cicloalquilo C₃₋₇, halógenocicloalquilo C₃₋₇ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, cicloalquil C₃₋₇-alquilo C₁₋₈, alquilcarbonilo C₁₋₈, halógenoalquilcarbonilo C₁₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alcoxicarbonilo C₁₋₈, halógenoalcoxicarbonilo C₁₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alquilsulfonilo C₁₋₈, halógenoalquilsulfonilo C₁₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, aril-alquilo C₁₋₈ y fenilsulfonilo, en donde dicho cicloalquilo C₃₋₇, cicloalquil C₃₋₇-alquilo C₁₋₈, aril-alquilo C₁₋₈ y fenilsulfonilo pueden sustituirse con uno o más sustituyentes R³ᵃ que pueden ser iguales o diferentes; W se selecciona independientemente del grupo que consiste en átomo de halógeno, hidroxilo, alquilo C₁₋₈, halógenoalquiloC₁₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alcoxi C₁₋₈, halógenoalcoxi C₁₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, hidroxialquilo C₁₋₈, alcoxi C₁₋₈-alquilo C₁₋₈, alquenilo C₂₋₈, halógenoalquenilo C₂₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alquinilo C₂₋₈, halógenoalquinilo C₂₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, cicloalquilo C₃₋₇, cicloalquenilo C₄₋₈, arilo, arilalquilo C₁₋₈, heterociclilo, heterociclil-alquilo C₁₋₈, ariloxi, heteroariloxi, arilsulfanilo, arilsulfinilo, arilsulfonilo, heteroarilsulfanilo, heteroarilsulfinilo, heteroarilsulfonilo, arilamino, heteroarilamino, ariloxialquilo C₁₋₈, heteroariloxi-alquilo C₁₋₈, arilsulfanil-alquilo C₁₋₈, arilsulfinil-alquilo C₁₋₈, arilsulfonil-alquilo C₁₋₈, heteroarilsulfanilalquilo C₁₋₈, heteroarilsulfinil-alquilo C₁₋₈, heteroarilsulfonil-alquilo C₁₋₈, arilamino-alquilo C₁₋₈, heteroarilamino-alquilo C₁₋₈, aril-alcoxi C₁₋₈, heteroaril-alcoxi C₁₋₈, aril-alquilsulfanilo C₁₋₈, aril-alquilsulfinilo C₁₋₈, aril-alquilsulfonilo C₁₋₈, heteroaril-alquilsulfanilo C₁₋₈, heteroaril-alquilsulfinilo C₁₋₈, heteroaril-alquilsulfonilo C₁₋₈, arilalquilamino C₁₋₈, heteroaril-alquilamino C₁₋₈, formilo, alquilocarbonilo C₁₋₈, (hidroxiimino)-alquilo C₁₋₈, (alcoxiimino C₁₋₈)-alquilo C₁₋₈, carboxilo, alcoxicarbonilo C₁₋₈, carbamoílo, alquilcarbamoílo C₁₋₈, dialquilcarbamoílo C₁₋₈, amino, alquilamino C₁₋₈, dialquilamino C₁₋₈, sulfanilo, alquilsulfanilo C₁₋₈, alquilsulfinilo C₁₋₈, alquilsulfonilo C₁₋₈, trialquilsililo C₁₋₆, tri(alquil C₁₋₈)sililoxi, tri(alquil C₁₋₈)sililoxialquilo C₁₋₈, ciano y nitro, donde dicho cicloalquilo C₃₋₇, cicloalquenilo C₄₋₈, heterociclilo, arilo y las porciones arilo, heterociclilo y heteroarilo de los grupos aril-alquilo C₁₋₈, heterociclil-alquilo C₁₋₈, ariloxi, heteroariloxi, arilsulfanilo, arilsulfinilo, arilsulfonilo, heteroarilsulfanilo, heteroarilsulfinilo, heteroarilsulfonilo, arilamino, heteroarilamino, ariloxi-alquilo C₁₋₈, heteroariloxi-alquilo C₁₋₈, arilsulfanil-alquilo C₁₋₈, arilsulfinil-alquilo C₁₋₈, arilsulfonil-alquilo C₁₋₈, heteroarilsulfanil-alquilo C₁₋₈, heteroarilsulfinil-alquilo C₁₋₈, heteroarilsulfonil-alquilo C₁₋₈, arilaminoalquilo C₁₋₈, heteroarilamino-alquilo C₁₋₈, aril-alcoxi C₁₋₈, heteroarilalcoxi C₁₋₈, aril-alquilsulfanilo C₁₋₈, aril-alquilsulfinilo C₁₋₈, arilalquilsulfonilo C₁₋₈, heteroaril-alquilsulfanilo C₁₋₈, heteroarilalquilsulfinilo C₁₋₈, heteroaril-alquilsulfonilo C₁₋₈, aril-alquilamino C₁₋₈, heteroaril-alquilamino C₁₋₈pueden sustituirse con uno o más sustituyentes Wᵃ que pueden ser iguales o diferentes; X se selecciona independientemente del grupo que consiste en átomo de halógeno, hidroxilo, alquilo C₁₋₈, halógenoalquilo C₁₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alcoxi C₁₋₈, halógenoalcoxi C₁₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alquenilo C₂₋₈, halógenoalquenilo C₂₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alquinilo C₂₋₈, halógenoalquinilo C₂₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, cicloalquilo C₃₋₇, cicloalquenilo C₄₋₇, arilo, heterociclilo, formilo, alquilcarbonilo C₁₋₈, (hidroxiimino)-alquilo C₁₋₈, (alcoxiimino C₁₋₈)-alquilo C₁₋₈, carboxilo, alcoxicarbonilo C₁₋₈, carbamoílo, alquilcarbamoílo C₁₋₈, dialquilcarbamoílo C₁₋₈, amino, alquilamino C₁₋₈, dialquilamino C₁₋₈, sulfanilo, alquilsulfanilo C₁₋₈, alquilsulfinilo C₁₋₈, alquilsulfonilo C₁₋₈, trialquilsililo C₁₋₆, ciano, nitro e hidroxialquilo C₁₋₈, donde dicho cicloalquilo C₃₋₇, cicloalquenilo C₄₋₇, arilo y heterociclilo pueden sustituirse con uno o más sustituyentes Xᵃ que pueden ser iguales o diferentes; Y se selecciona independientemente del grupo que consiste en átomo de halógeno, hidroxilo, alquilo C₁₋₈, halógenoalquilo C₁₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alcoxi C₁₋₈, halógenoalcoxi C₁₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alquenilo C₂₋₈, halógenoalquenilo C₂₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, alquinilo C₂₋₈, halógenoalquinilo C₂₋₈ que comprende hasta 9 átomos de halógeno que pueden ser iguales o diferentes, cicloalquilo C₃₋₇, cicloalquenilo C₄₋₇, arilo, heterociclilo, formilo, alquilcarbonilo C₁₋₈, (hidroxiimino)-alquilo C₁₋₈, (alcoxiimino C₁₋₈)-alquilo C₁₋₈, carboxilo, alcoxicarbonilo C₁₋₈, carbamoílo, alquilcarbamoílo C₁₋₈, dialquilcarbamoílo C₁₋₈, amino, alquilamino C₁₋₈, dialquilamino C₁₋₈, sulfanilo, alquilsulfanilo C₁₋₈, alquilsulfinilo C₁₋₈, alquilsulfonilo C₁₋₈, trialquilsililo C₁₋₆, ciano y nitro, donde dicho cicloalquilo C₃₋₇, cicloalquenilo C₄₋₇, arilo y heterociclilo pueden sustituirse con uno o más sustituyentes Yᵃ que pueden ser iguales o diferentes; Zᵃ, R³ᵃ, Wᵃ, Xᵃ e Yᵃ se seleccionan independientemente del grupo que consiste en átomo de halógeno, nitro, hidroxilo, ciano, carboxilo, amino, sulfanilo, pentafluoro-l⁶-sulfanilo, formilo, carbamoílo, carbamato, alquilo C₁₋₈, cicloalquilo C₃₋₇, halógenoalquilo C₁₋₈ que tiene de 1 a 5 átomos de halógeno, halógenocicloalquilo C₃₋₈ que tiene de 1 a 5 átomos de halógeno, alquenilo C₂₋₈, alquinilo C₂₋₈, alquilamino C₁₋₈, dialquilamino C₁₋₈, alcoxi C₁₋₈, halógenoalcoxi C₁₋₈ que tiene de 1 a 5 átomos de halógeno, alquilsulfanilo C₁₋₈, halógenoalquilsulfanilo C₁₋₈ que tiene de 1 a 5 átomos de halógeno, alquilcarbonilo C₁₋₈, halógenoalquilcarbonilo C₁₋₈ que tiene de 1 a 5 átomos de halógeno, alquilcarbamoílo C₁₋₈, dialquilcarbamoílo C₁₋₈, alcoxicarbonilo C₁₋₈, halógenoalcoxicarbonilo C₁₋₈ que tiene de 1 a 5 átomos de halógeno, alquilcarboniloxi C₁₋₈, halógenoalquilcarboniloxi C₁₋₈ que tiene de 1 a 5 átomos de halógeno, alquilcarbonilamino C₁₋₈, halógenoalquilcarbonilamino C₁₋₈ que tiene de 1 a 5 átomos de halógeno, alquilsulfanilo C₁₋₈, halógenoalquilsulfanilo C₁₋₈ que tiene de 1 a 5 átomos de halógeno, alquilsulfinilo C₁₋₈, halógenoalquilsulfinilo C₁₋₈ que tiene de 1 a 5 átomos de halógeno, alquilsulfonilo C₁₋₈ y halógenoalquilsulfonilo C₁₋₈ que tiene de 1 a 5 átomos de halógeno, o una sal o N-óxido de este, y (B) o un compuesto activo adicional seleccionado de los siguientes grupos (1) inhibidores de la síntesis de ergosterol, (2) inhibidores de la cadena respiratoria en el complejo I o II, (3) inhibidores de la cadena respiratoria en el complejo III, (4) inhibidores de la mitosis y de la división celular, (5) compuestos capaces de tener una acción multisitio, (6) compuestos capaces de inducir una defensa del huésped, (7) inhibidores de la biosíntesis de aminoácidos y/o proteínas, (8) inhibidores de la producción de ATP, (9) inhibidores de la síntesis de la pared celular, (10) inhibidores de la síntesis de lípidos y de la membrana, (11) inhibidores de la biosíntesis de melanina, (12) inhibidores de la síntesis de ácidos nucleicos, (13) inhibidores de la transducción de señal, (14) compuestos capaces de actuar como desacopladores, (15) otros fungicidas, en donde los compuestos (A) y (B) están presentes en una relación en peso A:B de 5000:1 a 1:5000. Reivindicación 4: La combinación del compuesto activo de acuerdo con la reivindicación 1, caracterizado por que el compuesto de la fórmula [1] es un compuesto de la fórmula [2] en donde W¹ es etilo o propilo; W⁴ es un átomo de hidrógeno; X átomo de hidrógeno, flúor o cloro; L es NH o CR¹R² en donde ambos R¹ y R² son átomos de hidrógeno; Q¹ es N o CH; Y² e Y³ son átomos de hidrógeno; Y⁴ es flúor; Y⁵ es flúor; Z es metilo; o una sal o N-óxido de estos. Reivindicación 12: La combinación de compuestos activos de acuerdo con cualquiera de las reivindicaciones 1 a 10, caracterizado por que el otro compuesto activo es seleccionado del grupo que consiste en (1,002) difenoconazol, (1,018) protioconazol, (1,020) espiroxamina, (1,021) tebuconazol, (1,081) mefentrifluconazol, (1,083) 2-[6-(4-bromofenoxi)-2-(trifluorometil)-3-piridil]-1-(1,2,4-triazol-1-il)propan-2-ol, (2,002) bixafen, (2,005) fluopiram, (2,038) N-(5-cloro-2-isopropilbencilo)-N-ciclopropil-3-(difluorometil)-5-fluoro-1-metil-1H-pirazol-4-carboxamida, (3,003) azoxistrobina, (3,016) picoxistrobina, (3,017) piraclostrobina, (3,020) trifloxistrobina, (3,030) (1S)-2,2-bis(4-fluorofenil)-1-metiletil N-{[3-(acetiloxi)-4-metoxi-2-piridil]carbonil}-L-alaninato, (5,010) ditianon, (5,018) propineb, (6,002) isotianil, (7,005) pirmetanil, (15,012) fosetil-aluminio y (15,066) (N’-[2-cloro-4-(2-fluorofenoxi)-5-metilfenil]-N-etil-N-metilimidoformamida). Reivindicación 13: La combinación de compuestos activos de acuerdo con cualquiera de las reivindicaciones 1 a 12 para uso en controlar microorganismos dañinos en protección de cultivos y en la protección de materiales. Reivindicación 14: La combinación de compuestos activos de acuerdo con cualquiera de las reivindicaciones 1 a 12 para uso en el tratamiento de una planta transgénica o para el tratamiento de semillas.Claim 1: The combination of active compound, characterized in that it comprises (A) a compound of formula [1] wherein A is a fused, partially saturated or unsaturated bicyclic heterocyclyl ring of 8, 9, 10 or 11 members comprising 1 atom from nitrogen and from 0 to 4 more heteroatoms independently selected from the group consisting of N, O and S; B is a 5-membered partially saturated or unsaturated heterocyclyl ring comprising 1, 2, 3 or 4 heteroatoms independently selected from the group consisting of N, O and S; Q is C; Z is selected from the group consisting of hydrogen atom, halogen atom, hydroxyl, C₁₋₈ alkyl, C₂₋₈ alkenyl, C₂₋₈ alkynyl, C₂₋₈ halogenoalkynyl comprising up to 9 halogen atoms which may be the same or different , C₁₋₈ alkoxy, C₁₋₈ halogenoalkyl comprising up to 9 halogen atoms which may be the same or different, C₂₋₈ halogenoalkenyl comprising up to 9 identical or different halogen atoms, C₁₋₈ halogenoalkoxy comprising up to 9 halogen atoms which may be the same or different, C₃₋₇-cycloalkyl, C₄₋₇-cycloalkenyl, aryl, heterocyclyl, formyl, C₁₋₈-alkylcarbonyl, (hydroxyimino)-C₁₋₈-alkyl, (C₁₋₈-alkoxyimino)-C₁₋-alkyl ₈, carboxyl, alcoxicarbonyl c₁₋₈, alkarbamoílo c₁₋₈, dialquarbamoílo c₁₋₈, alquine , cyano and nitro, wherein said C₃₋₇ cycloalkyl, C₄₋₇ cycloalkenyl, aryl and heterocyclyl may be substituted with one or more substituents Zᵃ which may be the same or different; m is 0, 1, 2, 3 or 4; n is 0, 1, 2, 3 or 4; p is 0, 1, 2, 3, 4 or 5; L is CR¹R² or NR³ wherein R¹ and R² are independently selected from the group consisting of hydrogen atom, halogen atom, C₁₋₈ alkoxy, and C₁₋₈ alkyl; R³ is selected from the group consisting of hydrogen atom, C₁₋₈ alkyl, C₁₋₈ halogenoalkyl comprising up to 9 halogen atoms which may be the same or different, C₂₋₈ alkenyl, C₂₋₈ halogenoalkenyl comprising up to 9 halogen atoms halogen which may be the same or different, C₃₋₈ alkynyl, C₃₋₈ halogenoalkynyl comprising up to 9 halogen atoms which may be the same or different, C₃₋₇ cycloalkyl, C₃₋₇ halogenocycloalkyl comprising up to 9 halogen atoms which may be same or different, C₃₋₇-cycloalkyl-C₁₋₈-alkyl, C₁₋₈-alkylcarbonyl, C₁₋₈-halogenoalkylcarbonyl comprising up to 9 halogen atoms which may be the same or different, C₁₋₈-alkoxycarbonyl, C₁₋₈-halogenoalkoxycarbonyl comprising up to 9 halogen atoms that may be the same or different, C₁₋₈ alkylsulfonyl, C₁₋₈ halogenoalkylsulfonyl comprising up to 9 halogen atoms that may be the same or different, aryl-C₁₋₈ alkyl and phenylsulfonyl, wherein said or C₃₋₇-cycloalkyl, C₃₋₇-cycloalkyl-C₁₋₈-alkyl, aryl-C₁₋₈-alkyl and phenylsulfonyl may be substituted with one or more R³ᵃ substituents which may be the same or different; W is independently selected from the group consisting of halogen atom, hydroxyl, C₁₋₈ alkyl, halogenoC₁₋₈ alkyl comprising up to 9 halogen atoms which may be the same or different, C₁₋₈ alkoxy, C₁₋₈ halogenoalkoxy comprising up to 9 halogen atoms which may be the same or different, C₁₋₈ hydroxyalkyl, C₁₋₈ alkoxy-C₁₋₈ alkyl, C₂₋₈ alkenyl, C₂₋₈ halogenoalkenyl comprising up to 9 halogen atoms which may be the same or different, C₂ alkynyl ₋₈, C₂₋₈ halogenoalkynyl comprising up to 9 halogen atoms which may be the same or different, C₃₋₇ cycloalkyl, C₄₋₈ cycloalkenyl, aryl, arylC₁₋₈alkyl, heterocyclyl, heterocyclyl-C₁₋₈ alkyl, aryloxy, heteroaryloxy , arylsulfanyl, arylsulfinyl, arylsulfonyl, heteroarylsulfanyl, heteroarylsulfinyl, heteroarylsulfonyl, arylamino, heteroarylamino, aryloxy-C 1₋ alkyl, heteroaryloxy-C 1₋ alkyl, arylsulfanyl-C 1₋ alkyl, arylsulfinyl-C 1₋ alkyl, arylsulfonyl-C₁₈,₋ alkyl heteroar C₁₋₈-ylsulfanylalkyl, heteroarylsulfinyl-C₁₋₈-alkyl, heteroarylsulfonyl-C₁₋₈-alkyl, arylamino-C₁₋₈-alkyl, heteroarylamino-C₁₋₈-alkyl, aryl-C₁₋₈-alkoxy, heteroaryl-C₁₋₈-alkoxy, aryl-alkylsulfanyl C₁₋₈, aryl-C₁₋₈-alkylsulfinyl, aryl-C₁₋₈-alkylsulfonyl, heteroaryl-C₁₋₈-alkylsulfanyl, heteroaryl-C₁₋₈-alkylsulfinyl, heteroaryl-C₁₋₈-alkylsulfonyl, aryl-C₁₋₈-alkylsulfonyl, heteroaryl-C₁₋₋-alkylamino , formyl, C₁₋₈-alkylcarbonyl, (hydroxyimino)-C₁₋₈-alkyl, (C₁₋₈-alkoxyimino)-C₁₋₈-alkyl, carboxyl, C₁₋₈-alkoxycarbonyl, carbamoyl, C₁₋₈-alkylcarbamoyl, C₁₈-dialkylcarbamoyl, amino C₁₋₈-alkylamino, C₁₋₈-dialkylamino, sulfanyl, C₁₋₈-alkylsulfanyl, C₁₋₈-alkylsulfinyl, C₁₋₈-alkylsulfonyl, C₁₋₆-trialkylsilyl, tri(C₁₋₈-alkyl)silyloxy, tri(C₁₋₈-alkyl)siloxy-C₈alkyl ₋₈, cyano and nitro, where said C₃₋₇ cycloalkyl, C₄₋₈ cycloalkenyl, heterocyclyl, aryl, and the aryl, heterocyclyl, and heteroaryl portions of aryl-C₁₋₈ alkyl, heterocyclyl-alk C₁₋₈-yl, aryloxy, heteroaryloxy, arylsulfanyl, arylsulfinyl, arylsulfonyl, heteroarylsulfanyl, heteroarylsulfinyl, heteroarylsulfonyl, arylamino, heteroarylamino, aryloxy-C₁₋₈-alkyl, heteroaryloxy-C₁₋₈-alkyl, arylsulfanyl-C₁₋₈-alkyl, aryl₁-Crylsulfinyl-alkyl ₋₈, arylsulfonyl-C₁₋₈-alkyl, heteroarylsulfanyl-C₁₋₈-alkyl, heteroarylsulfinyl-C₁₋₈-alkyl, heteroarylsulfonyl-C₁₋₈-alkyl, arylamino-C₁₋₈-alkyl, heteroarylamino-C₁₋₈-alkyl, aryl-C₈-alkoxy,₋ C₁₋₈ heteroarylalkoxy, C₁₋₈ arylalkylsulfinyl, C₁₋₈ arylalkylsulfinyl, C₁₋₈ arylalkylsulfonyl, C₁₋₈ heteroarylalkylsulfanyl, C₁₋₈ heteroarylalkylsulfinyl, C₁₋₋heteroarylalkylsulfinyl, C₁₋₋alkylalkylsulfonyl, aryl₋₈, aryl heteroaryl-C₁₋₈alkylamino may be substituted with one or more substituents Wᵃ which may be the same or different; X is independently selected from the group consisting of halogen atom, hydroxyl, C₁₋₈ alkyl, C₁₋₈ halogenoalkyl comprising up to 9 halogen atoms which may be the same or different, C₁₋₈ alkoxy, C₁₋₈ halogenoalkoxy comprising up to 9 halogen atoms which may be the same or different, C₂₋₈ alkenyl, C₂₋₈ halogenoalkenyl comprising up to 9 halogen atoms which may be the same or different, C₂₋₈ alkynyl, C₂₋₈ halogenoalkynyl comprising up to 9 halogen atoms which may be the same or different, C₃₋₇-cycloalkyl, C₄₋₇-cycloalkenyl, aryl, heterocyclyl, formyl, C₁₋₈-alkylcarbonyl, (hydroxyimino)-C₁₋₈-alkyl, (C₁₋₈-alkoxyimino)-C₁₋₈-alkyl, carboxyl , alcoxicarbonyl c₁₋₈, carbamoílo, alkarbamoílo c₁₋₈, dialquilcarbamoílo c₁₋₈, amino, alqumina c₁₋₈, dialquilamin c₁₋₈, sulphanyl, alklim c₁₋₈, alkloc ₆, cyano, nitro and C₁₋₈ hydroxyalkyl, where said cycloalkyl or C₃₋₇, C₄₋₇ cycloalkenyl, aryl and heterocyclyl may be substituted with one or more substituents Xᵃ which may be the same or different; Y is independently selected from the group consisting of halogen atom, hydroxyl, C₁₋₈ alkyl, C₁₋₈ halogenoalkyl comprising up to 9 halogen atoms which may be the same or different, C₁₋₈ alkoxy, C₁₋₈ halogenoalkoxy comprising up to 9 halogen atoms which may be the same or different, C₂₋₈ alkenyl, C₂₋₈ halogenoalkenyl comprising up to 9 halogen atoms which may be the same or different, C₂₋₈ alkynyl, C₂₋₈ halogenoalkynyl comprising up to 9 halogen atoms which may be the same or different, C₃₋₇-cycloalkyl, C₄₋₇-cycloalkenyl, aryl, heterocyclyl, formyl, C₁₋₈-alkylcarbonyl, (hydroxyimino)-C₁₋₈-alkyl, (C₁₋₈-alkoxyimino)-C₁₋₈-alkyl, carboxyl , alcoxicarbonyl c₁₋₈, carbamoílo, alkarbamoílo c₁₋₈, dialquilcarbamoílo c₁₋₈, amino, alqumina c₁₋₈, dialquilamin c₁₋₈, sulphanyl, alklim c₁₋₈, alkloc ₆, cyano and nitro, where said C₃₋₇ cycloalkyl, cycloalkenyl or C₄₋₇, aryl and heterocyclyl may be substituted with one or more substituents Yᵃ which may be the same or different; Zᵃ, R³ᵃ, Wᵃ, Xᵃ and Yᵃ are independently selected from the group consisting of halogen atom, nitro, hydroxyl, cyano, carboxyl, amino, sulfanyl, pentafluoro-l⁶-sulfanyl, formyl, carbamoyl, carbamate, C₁₋₈ alkyl, C₃₋₇ cycloalkyl, C₁₋₈ halogenoalkyl having 1 to 5 halogen atoms, C₃₋₈ halogenocycloalkyl having 1 to 5 halogen atoms, C₂₋₈ alkenyl, C₂₋₈ alkynyl, C₁₋₈ alkylamino, C₁ dialkylamino ₋₈, C₁₋₈ alkoxy, C₁₋₈ halogenalkoxy having 1 to 5 halogen atoms, C₁₋₈ alkylsulfanyl, C₁₋₈ halogenoalkylsulfanyl having 1 to 5 halogen atoms, C₁₋₈ alkylcarbonyl, C₁₈₋ halogenoalkylcarbonyl having 1 to 5 halogen atoms, C₁₋₈ alkylcarbamoyl, C₁₋₈ dialkylcarbamoyl, C₁₋₈ alkoxycarbonyl, C₁₋₈ halogenoalkoxycarbonyl having 1 to 5 halogen atoms, C₁₋₈ alkylcarbonyloxy, C₈₋ halogenoalkylcarbonyloxy from 1 to 5 halogen atoms, C₁₋₈ alkylcarbonylamino, C₁₋₈ halogenoalkylcarbonylamino having from 1 to 5 halogen atoms, C₁₋₈ alkylsulfanyl, C₁₋₈ halogenoalkylsulfanyl having 1 to 5 halogen atoms, C₁₋₈ alkylsulfinyl, C₁₋₈ halogenoalkylsulfinyl having 1 to 5 halogen atoms, C₁₋₈ alkylsulfonyl, and ₂alkylsulfonyl ₋₈ having 1 to 5 halogen atoms, or a salt or N-oxide thereof, and (B) or an additional active compound selected from the following groups (1) ergosterol synthesis inhibitors, (2) inhibitors of the respiratory chain in complex I or II, (3) inhibitors of the respiratory chain in complex III, (4) inhibitors of mitosis and cell division, (5) compounds capable of having a multisite action, (6 ) compounds capable of inducing host defense, (7) inhibitors of amino acid and/or protein biosynthesis, (8) inhibitors of ATP production, (9) inhibitors of cell wall synthesis, (10) inhibitors of lipid and membrane synthesis, (11) inhibitors of mel biosynthesis anine, (12) nucleic acid synthesis inhibitors, (13) signal transduction inhibitors, (14) compounds capable of acting as uncouplers, (15) other fungicides, wherein compounds (A) and (B) they are present in a weight ratio A:B of 5000:1 to 1:5000. Claim 4: The active compound combination according to claim 1, characterized in that the compound of the formula [1] is a compound of the formula [2] wherein W¹ is ethyl or propyl; W⁴ is a hydrogen atom; X hydrogen, fluorine or chlorine atom; L is NH or CR¹R² where both R¹ and R² are hydrogen atoms; Q¹ is N or CH; Y² and Y³ are hydrogen atoms; Y⁴ is fluorine; Y⁵ is fluorine; Z is methyl; or a salt or N-oxide of these. Claim 12: The combination of active compounds according to any of claims 1 to 10, characterized in that the other active compound is selected from the group consisting of (1.002) difenoconazole, (1.018) prothioconazole, (1.020) spiroxamine, (1.021 ) tebuconazole, (1,081) mefentrifluconazole, (1,083) 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan- 2-ol, (2.002) bixafen, (2.005) fluopyram, (2.038) N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole -4-Carboxamide, (3.003) Azoxystrobin, (3.016) Picoxystrobin, (3.017) Pyraclostrobin, (3.020) Trifloxystrobin, (3.030) (1S)-2,2-bis(4-fluorophenyl)-1-methylethyl N-{[ 3-(acetyloxy)-4-methoxy-2-pyridyl]carbonyl}-L-alaninate, (5.010) dithianon, (5.018) propineb, (6.002) isotianyl, (7.005) pyrmethanil, (15.012) fosetyl-aluminum, and (15.066 ) (N-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N-methylimidoformamide). Claim 13: The combination of active compounds according to any of claims 1 to 12 for use in controlling harmful microorganisms in crop protection and in the protection of materials. Claim 14: The combination of active compounds according to any of claims 1 to 12 for use in the treatment of a transgenic plant or for the treatment of seeds.

ARP200100595A 2019-03-05 2020-03-04 COMBINATION OF ACTIVE COMPOUNDS AR118247A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19160679 2019-03-05

Publications (1)

Publication Number Publication Date
AR118247A1 true AR118247A1 (en) 2021-09-22

Family

ID=65729092

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200100595A AR118247A1 (en) 2019-03-05 2020-03-04 COMBINATION OF ACTIVE COMPOUNDS

Country Status (2)

Country Link
AR (1) AR118247A1 (en)
WO (1) WO2020178307A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230112306A1 (en) * 2020-03-13 2023-04-13 Syngenta Crop Protection Ag Methods of controlling or preventing infestation of soybean plants by the phytopathogenic microorganism corynespora cassiicola
US10894812B1 (en) 2020-09-30 2021-01-19 Alpine Roads, Inc. Recombinant milk proteins
US10947552B1 (en) 2020-09-30 2021-03-16 Alpine Roads, Inc. Recombinant fusion proteins for producing milk proteins in plants
EP4222167A1 (en) 2020-09-30 2023-08-09 Nobell Foods, Inc. Recombinant milk proteins and food compositions comprising the same
CN112602718A (en) * 2020-12-15 2021-04-06 美丰农业科技(上海)有限公司 Nematicidal agricultural composition containing pyraoxystrobin and cyclobutrifuram
WO2022171709A1 (en) 2021-02-11 2022-08-18 Syngenta Crop Protection Ag Fungicidal compositions
CN113845524B (en) * 2021-10-29 2023-11-07 四川农业大学 Spiropyrrolindolone compound and preparation method and application thereof
WO2023148343A1 (en) 2022-02-04 2023-08-10 Syngenta Crop Protection Ag Fungicidal compositions
WO2024149772A1 (en) 2023-01-10 2024-07-18 Syngenta Crop Protection Ag Fungicidal compositions

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3639877A1 (en) 1986-11-21 1988-05-26 Bayer Ag HETARYLALKYL SUBSTITUTED 5- AND 6-RINGHETEROCYCLES
PL198772B1 (en) 1997-05-09 2008-07-31 Agraquest Novel Bacillus strain for fighting against plant diseases and root pests of Diabrotica cereals
US6245551B1 (en) 1999-03-30 2001-06-12 Agraquest, Inc. Strain of Bacillus pumilus for controlling plant diseases caused by fungi
JP4071036B2 (en) 2001-11-26 2008-04-02 クミアイ化学工業株式会社 Bacillus sp. D747 strain and plant disease control agent and pest control agent using the same
GB0213715D0 (en) 2002-06-14 2002-07-24 Syngenta Ltd Chemical compounds
TWI312272B (en) 2003-05-12 2009-07-21 Sumitomo Chemical Co Pyrimidine compound and pests controlling composition containing the same
GB0414438D0 (en) 2004-06-28 2004-07-28 Syngenta Participations Ag Chemical compounds
MX2007004710A (en) 2004-10-20 2007-06-14 Kumiai Chemical Industry Co 3-triazolylphenyl sulfide derivative and insecticide/acaricide/ nematicide containing the same as active ingredient.
ES2550398T3 (en) 2005-10-06 2015-11-06 Nippon Soda Co., Ltd. Cross-linked cyclic amine compounds and agents for pest control
JP5268461B2 (en) 2008-07-14 2013-08-21 Meiji Seikaファルマ株式会社 PF1364 substance, its production method, production strain, and agricultural and horticultural insecticide containing the same as an active ingredient
CN101337937B (en) 2008-08-12 2010-12-22 国家农药创制工程技术研究中心 N-benz-3-substituted amino pyrazoles compounds with insecticidal activity
CN101337940B (en) 2008-08-12 2012-05-02 国家农药创制工程技术研究中心 Nitrogen heterocyclic ring dichloro allyl ether compound with insecticidal activity
CN101715774A (en) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 Preparation and use of compound having insecticidal activity
EP2184273A1 (en) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen substituted compounds as pesticides
GB0820344D0 (en) 2008-11-06 2008-12-17 Syngenta Ltd Herbicidal compositions
SI2369934T1 (en) 2008-12-12 2014-07-31 Syngenta Participations Ag Spiroheterocyclic n-oxypiperidines as pesticides
WO2011085575A1 (en) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 Ortho-heterocyclyl formanilide compounds, their synthesis methods and use
AR081721A1 (en) 2010-02-25 2012-10-17 Nippon Soda Co CYCLING AND ACARICIDE AMINA COMPOUND
KR20130080485A (en) 2010-05-31 2013-07-12 신젠타 파티서페이션즈 아게 Method of crop enhancement
MX363956B (en) 2010-08-31 2019-04-09 Meiji Seika Pharma Co Ltd Star Noxious organism control agent.
CN101967139B (en) 2010-09-14 2013-06-05 中化蓝天集团有限公司 Fluoro methoxylpyrazole-containing o-formylaminobenzamide compound, synthesis method and application thereof
WO2013050317A1 (en) 2011-10-03 2013-04-11 Syngenta Limited Polymorphs of an isoxazoline derivative
CN102391261A (en) 2011-10-14 2012-03-28 上海交通大学 N-substituted dioxazine compound as well as preparation method and application thereof
TWI566701B (en) 2012-02-01 2017-01-21 日本農藥股份有限公司 Arylalkyloxypyrimidine derivatives and agrohorticultural insecticides comprising said derivatives as active ingredients, and method of use thereof
WO2013144213A1 (en) 2012-03-30 2013-10-03 Basf Se N-substituted pyridinylidene compounds and derivatives for combating animal pests
EP2647626A1 (en) 2012-04-03 2013-10-09 Syngenta Participations AG. 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides
NZ715920A (en) 2012-04-27 2016-07-29 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
CN103232431B (en) 2013-01-25 2014-11-05 青岛科技大学 Dihalogenated pyrazole amide compound and its use
CN103109816B (en) 2013-01-25 2014-09-10 青岛科技大学 Thiobenzamide compounds and application thereof
WO2014158644A1 (en) 2013-03-13 2014-10-02 Dow Agrosciences Llc Process for the preparation of triaryl rhamnose carbamates
JP6595985B2 (en) 2013-05-23 2019-10-23 シンジェンタ パーティシペーションズ アーゲー Tank mix formulation
CN103265527B (en) 2013-06-07 2014-08-13 江苏省农用激素工程技术研究中心有限公司 Anthranilamide compound as well as preparation method and application thereof
CN103524422B (en) 2013-10-11 2015-05-27 中国农业科学院植物保护研究所 Benzimidazole derivative, and preparation method and purpose thereof
EP3057429A4 (en) 2013-10-17 2017-08-09 Dow AgroSciences LLC Processes for the preparation of pesticidal compounds
JP2016539092A (en) 2013-10-17 2016-12-15 ダウ アグロサイエンシィズ エルエルシー Method for producing pest control compound
WO2016005276A1 (en) 2014-07-07 2016-01-14 Bayer Cropscience Aktiengesellschaft Process for preparing fluorinated iminopyridine compounds
CN107205396B (en) 2015-02-17 2019-08-30 日本曹达株式会社 Composition pesticide
BR112017020604B1 (en) 2015-03-26 2022-09-27 Bayer Cropscience Lp COMPOSITION AND METHOD FOR TREATMENT OF A PLANT TO CONTROL A DISEASE
TWI782983B (en) 2017-04-27 2022-11-11 德商拜耳廠股份有限公司 Heteroarylphenylaminoquinolines and analogues

Also Published As

Publication number Publication date
WO2020178307A1 (en) 2020-09-10

Similar Documents

Publication Publication Date Title
AR118247A1 (en) COMBINATION OF ACTIVE COMPOUNDS
AR122776A2 (en) PARASITICIDAL COMPOSITIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, THEIR METHODS AND USES
AR113964A1 (en) CARBAMOIL CYCLOHEXYL N-LINKED ACIDS OF TRIAZOLE AS ANTAGONISTS OF LPA
AR088175A1 (en) 3-PIRIMIDIN-4-IL-OXAZOLIDIN-2-USEFUL WAVES TO TREAT CANCER AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RU2016152470A (en) APPLICATION OF SUBSTITUTED OXADIAZOLES FOR THE FIGHT AGAINST PHYTOPATHOGENIC MUSHROOMS
RU2016103149A (en) PESTICIDO-ACTIVE BI-OR TRICYCLIC HETEROCYCLES WITH SURFACE-CONTAINING SUBSTITUTES
AR104915A1 (en) DERIVATIVES OF 2- (PHENYLOXY OR PHENYLTIUM) PYRIMIDINE AS HERBICIDES
AR058139A1 (en) MICROBIOCIDES AND FUNGICIDES AND CONTROL METHODS
AR084308A1 (en) INSECTICIDE COMPOUNDS DERIVED FROM TRIAZOL
AR067663A1 (en) HETEROCICLIC DERIVATIVES OF ETILOXI AMIDAS, COMPOSITIONS THAT INCLUDE THEM AND USES OF THE SAME IN AGRICULTURE OR HORTICULTURE, AS ANTIFUNGIC AGENTS.
AR113965A1 (en) TRIAZOLE AZOLES CYCLOHEXYL ACIDS AS ANTAGONISTS OF LPA
AR055431A1 (en) ACID DERIVATIVES 4-AMINO-TIENO [3,2-C] PIRIDINA-7-CARBOXILICO
AR081834A1 (en) N - [(HET) ARILALQUIL)] PIRAZOLOCARBOXAMIDAS OR THYCARBOXAMIDES AND HETEROSUSTITUDED ANALOGS, FUNGUITED COMPOSITIONS CONTAINING THEM AND METHODS FOR CONTROLLING FITOPATOGEN FUNGI IN CROPS USING SUCH COMPOUNDS OR COMPOSITIONS
AR087607A1 (en) DERIVATIVES OF PIRIDAZINONA
AR120074A1 (en) FUSED HETEROCYCLIC COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS
AR086456A1 (en) INSECTICIDE COMPOUNDS BASED ON ARILTIO ACETAMIDE DERIVATIVES
AR089800A1 (en) SOLID HERBICIDE COMPOSITIONS IMPROVED WITH ADJUSTER INCORPORATED
AR118435A1 (en) AZA-BENZOTHIOPHENE AND AZA-BENZOFURAN COMPOUNDS AS ANTIHELMINTICS
AR110367A1 (en) ACTIVE COMPOUND COMBINATIONS
AR090376A1 (en) HERBICIDE COMPOUNDS
RU2014109747A (en) MORPHOLIN-SUBSTITUTED UREA OR CARBAMATE DERIVATIVES AS MTOR INHIBITORS
AR105425A1 (en) IMIDAZOL DERIVATIVES AS A PESTICIDE WITH SUBSTITUTES CONTAINING SULFUR
RU2020131012A (en) 7-SUBSTITUTED SULFONIMIDOILPURINONE COMPOUNDS AND THEIR DERIVATIVES FOR THE TREATMENT AND PREVENTION OF LIVER CANCER
AR116022A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
AR093782A1 (en) USE OF ANTRANILAMIDE COMPOUNDS TO REDUCE VIRAL INFECTIONS WHOSE VECTOR IS AN INSECT

Legal Events

Date Code Title Description
FB Suspension of granting procedure